Bioxytran, Inc
BIXT· OTC
BIXTBioxytran, Inc
Filed Apr 9, 2021 · 10-K · 99 days after period end · 0001785982-21-000076
derived · Computed from the longer spans the company filed.
| Metric | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures | Q4 2017 | Q4 2016dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | — | $32.19K | $58.20K |
| Net Income | -$871.39K | -$662.66K | -$86.41K | $135.28K |
| EPS Diluted | — | — |
Bioxytran, Inc · CIK 1445815 · Engraved from SEC EDGAR
| $0.00 |
| — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2020 · filed Apr 9, 2021 · 99 d after period end
